Kairo Bio
Saint-Mandé, France
Kairo Bio develops a translational precision immunology platform designed to improve decision-making from preclinical development to Phase II. Built on functional human immune modeling and standardized immune perturbation data, Kairo helps biopharma partners identify translational biomarkers, stratify patients, and better predict clinical responses in immune-mediated diseases while supporting more human-relevant translational approaches.
Only accessible to MedStartr community members.
Join nowCompany Info
- Website
- www.kairo.bio/
Only accessible to MedStartr community members.
Join nowWhat do you think of Kairo Bio?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now